- Home
- NRT vs ALGS Comparison
NRT vs ALGS Comparison
Compare NRT & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRT
- ALGS
- Stock Information
- Founded
- NRT 1975
- ALGS 2018
- Country
- NRT United States
- ALGS United States
- Employees
- NRT N/A
- ALGS N/A
- Industry
- NRT Oil & Gas Production
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- NRT Energy
- ALGS Health Care
- Exchange
- NRT Nasdaq
- ALGS Nasdaq
- Market Cap
- NRT 44.0M
- ALGS 50.4M
- IPO Year
- NRT N/A
- ALGS 2020
- Fundamental
- Price
- NRT $4.91
- ALGS $7.39
- Analyst Decision
- NRT
- ALGS Strong Buy
- Analyst Count
- NRT 0
- ALGS 1
- Target Price
- NRT N/A
- ALGS $70.00
- AVG Volume (30 Days)
- NRT 25.2K
- ALGS 130.6K
- Earning Date
- NRT 05-30-2025
- ALGS 08-05-2025
- Dividend Yield
- NRT 9.60%
- ALGS N/A
- EPS Growth
- NRT 24.05
- ALGS N/A
- EPS
- NRT 0.59
- ALGS N/A
- Revenue
- NRT $6,184,173.00
- ALGS $3,270,000.00
- Revenue This Year
- NRT N/A
- ALGS N/A
- Revenue Next Year
- NRT N/A
- ALGS $51.55
- P/E Ratio
- NRT $8.54
- ALGS N/A
- Revenue Growth
- NRT 18.55
- ALGS N/A
- 52 Week Low
- NRT $3.88
- ALGS $3.76
- 52 Week High
- NRT $6.90
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- NRT 43.33
- ALGS 53.13
- Support Level
- NRT $4.88
- ALGS $6.88
- Resistance Level
- NRT $5.32
- ALGS $8.66
- Average True Range (ATR)
- NRT 0.15
- ALGS 0.78
- MACD
- NRT -0.06
- ALGS -0.08
- Stochastic Oscillator
- NRT 5.26
- ALGS 30.90
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.